Home/T-Knife Therapeutics/Camille Landis
CL

Camille Landis

Chief Business Officer / Chief Financial Officer

T-Knife Therapeutics

Therapeutic Areas

T-Knife Therapeutics Pipeline

DrugIndicationPhase
TK-6302PRAME-positive solid tumorsPre-clinical